Cornerstones of CRISPR–Cas in drug discovery and therapy

Christof Fellmann, Benjamin G. Gowen, Pei‐Chun Lin, Jennifer A. Doudna, Jacob E. Corn

View at source ↗Review445 citations
The abstract is not reproduced here because its license does not permit redistribution. Read it at the original source.

Record

Archive ID
doi:10.1038/nrd.2016.238
Published
Dec 23, 2016
Venue
Nature Reviews Drug Discovery
DOI
10.1038/nrd.2016.238
PubMed
28008168
Categories
CRISPR and Genetic Engineering
Provenance
openalex

Topics